Changchun Ma
Overview
Explore the profile of Changchun Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai R, Ke L, Zhao Y, Zhao J, Zhang H, Zheng P, et al.
Int J Cancer
. 2024 Dec;
156(8):1644-1655.
PMID: 39629979
Colorectal cancer (CRC) still remains the leading cause of cancer death worldwide. This study aimed to profile the metabolic differences of colorectal cancer tissues (CCT) at different stages and sites,...
2.
Lin X, Guan T, Xu Y, Li Y, Lin Y, Chen S, et al.
Front Immunol
. 2024 Apr;
15:1337489.
PMID: 38566988
Introduction: Chimeric antigen receptor natural killer (CAR-NK) cells have been found to be successful in treating hematologic malignancies and present potential for usage in solid tumors. Methods: In this study,...
3.
Zhao Y, Ma C, Cai R, Xin L, Li Y, Ke L, et al.
Nat Commun
. 2024 Mar;
15(1):2463.
PMID: 38504100
Metabolic changes precede malignant histology. However, it remains unclear whether detectable characteristic metabolome exists in esophageal squamous cell carcinoma (ESCC) tissues and biofluids for early diagnosis. Here, we conduct NMR-...
4.
Lin X, Guan T, Li Y, Lin Y, Huang G, Lin Y, et al.
Front Immunol
. 2024 Feb;
15:1337557.
PMID: 38390321
Introduction: The clinical efficacy of CAR-NK cells against CD19-expressing blood cancers has been demonstrated, and they have shown potential for treating solid tumors as well. However, the efficacy of CAR-NK...
5.
Liu T, Dai X, Xu Y, Guan T, Hong L, Zaib T, et al.
J Transl Med
. 2023 Oct;
21(1):710.
PMID: 37817249
Background: Chimeric antigen receptor NK (CAR-NK) cell therapy is one of the most promising immunotherapies. Although it has shown a significant therapeutic effect in hematologic malignancies, few successes have been...
6.
Wang H, Su C, Li Z, Ma C, Hong L, Li Z, et al.
Front Immunol
. 2023 Mar;
14:1091098.
PMID: 36891293
Recent reports indicate that immune cells in solid cancers have significant predictive and therapeutic value. IgG4 is a subclass of IgG and we recently found that it exerted an inhibitory...
7.
Ouyang T, Ma C, Zhao Y, Ye W, Zhao J, Cai R, et al.
Front Oncol
. 2023 Feb;
13:1082841.
PMID: 36756157
Introduction: The goal of this study was to establish an optimized metabolic panel by combining serum and urine biomarkers that could reflect the malignancy of cancer tissues to improve the...
8.
Tong M, Yan X, Jiang Y, Jin Z, Zhu S, Zou L, et al.
Mediterr J Hematol Infect Dis
. 2022 May;
14(1):e2022033.
PMID: 35615329
Background: COVID-19 is characterized by endothelial dysfunction and is presumed to have long-term cardiovascular sequelae. In this cross-sectional study, we aimed to explore the serum levels of endothelial biomarkers in...
9.
Zhang J, Huang L, Wu F, Wang G, Wu L, Huang B, et al.
J Appl Clin Med Phys
. 2021 May;
22(5):139-146.
PMID: 33934511
Purpose: Our study aimed to improve the dosimetry of post modified radical mastectomy intensity-modulated radiotherapy (PMRM-IMRT) for left-sided breast cancer patients by tailoring and minimizing PTV expansion three-dimensionally utilizing 4D...
10.
Ye W, Lin Y, Bezabeh T, Ma C, Liang J, Zhao J, et al.
NMR Biomed
. 2021 Mar;
34(6):e4505.
PMID: 33783927
Serum metabolites of healthy controls and esophageal cancer (EC) patients have previously been compared to predict cancer-specific profiles. However, the association between metabolic alterations in serum samples and esophageal tissues...